Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REGORAFENIB vs RELUGOLIX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REGORAFENIB vs RELUGOLIX: Safety Overview

Metric REGORAFENIB RELUGOLIX
Total FAERS Reports 9,441 20,660
Deaths Reported 1,869 958
Death Rate 19.8% 4.6%
Hospitalizations 3,363 1,699
Average Patient Age 62.2 yrs 72.4 yrs
% Female Patients 39.9% 1.4%
FDA Approval Date Jan 13, 2025 Dec 18, 2020
Manufacturer Bayer HealthCare Pharmaceuticals Inc. Sumitomo Pharma America, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription